December 2016
-
MedImmune has announced its submission of a supplemental Biologics License Application to the FDA for a version of its FluMist intranasal influenza vaccine that includes 4 strains of influenza virus as opposed to the usual… Read more . . .
-
Inhaled antibiotic developer Insmed has hired Andrea (“Andi”) Holtzman Drucker as its Senior Vice President, General Counsel and Corporate Secretary, which is a newly-created position reporting directly to Insmed President and CEO Timothy Whitten. Drucker… Read more . . .
-
A study by Harvard researchers published in the New England Journal of Medicine found that patients reported similar relief of symptoms from use of a placebo inhaler compared to use of an albuterol inhaler. Although… Read more . . .
-
The Allergy & Asthma Network Mothers of Asthmatics (AANMA) is currently sponsoring an Ultimate Inhaler Contest,” challenging lay people to “invent the ultimate inhaled medication device.” Read more . . .
-
University of South Florida researchers have successfully delivered an anti-inflammatory drug to the lower lungs of rats by injecting a formulation of Sertolli cells, chitosan nanoparticles, and curcumin into the rats’ tails. Over 90% of… Read more . . .
-
After a successful audit by the UK MHRA, Melbourn Scientific has been issued a manufacturing license and now has the capability to manufacture OINDPs for use in Phase 1 and 2 clinical trials, according to… Read more . . .
-
Aerogen has introduced a new nebulizer that is integrated into the Maquet SERVO-i ventilator. The high efficiency vibrating mesh Aeroneb nebulizer can be retrofitted to existing ventilators or purchased with new units. Aerogen CEO John… Read more . . .
-
UK laboratory equipment company Elite Measurement Solutions is now distributing the Relequa Moisture Profiling System which determines equilibrium relative humidity for the optimization of dry powder and other formulations. Moisture profiling can provide information relevant… Read more . . .
-
Existing shareholders have agreed to purchase additional Aradigm Corporation common stock for a total of $4.75 million. The three shareholders will pay $0.19 per share for 25 million shares. The net proceeds for Aradigm after… Read more . . .
-
The European Commission has granted marketing authorization for Nycomed’s single dose Instanyl fentanyl nasal spray for the treatment of breakthrough pain in cancer patients. A multi-dose Instanyl product was approved by the EC in 2009… Read more . . .
Featured event:
5th Annual Inhaled & Nasal Biologics | DNA Forum
5th Annual Inhaled & Nasal Biologics | DNA Forum
24th-25th September 2026, Cambridge, UK
Join us for a ground-breaking and insightful forum: Two days of cutting-edge talks and networking opportunities in this complex area of drug and vaccine development.
With renowned industry leaders who will share their insights and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don’t miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
Get online to see speakers announced so far. Registration is live – save your seat now!
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland